03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Herzuma 440mg : | |
Type | Medicine Authorised |
Originator | Trazimera 440mg |
Agent | Droguerie Columbus |
Distributor | Droguerie Columbus |
Laboratory | Hikma Pharmaceuticals |
Responsible Party | Hikma Pharmaceuticals |
Origin | Jordan |
Manufacturer | Celtrion inc |
Manufacturing Type | G |
Origin | South Korea |
ATC | L01XC03 |
Herzuma 440mg :
Herzuma 440mg :
Herzuma 440mg :
Herzuma 440mg :
Herzuma 440mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very Common |
Acne | Common |
Acute pulmonary oedema | Not known |
Acute respiratory distress syndrome | Not known |
Alopecia | Very Common |
Anaemia | Very Common |
Anaphylactic reactions | Very Common |
Anaphylactic shock | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
Anorexia | Common |
Anxiety | Common |
Arrhythmia | Very Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
Arthritis | Very rare |
Asthenia | Very Common |
Asthma | Common |
Ataxia | Not known |
Back pain | Common |
Bone pain | Common |
Bradycardia | Not known |
Bronchitis | Not known |
Bronchospasm | Not known |
Cardiac flutter | Very Common |
Cardiogenic shock | Not known |
Cardiomyopathy | Very rare |
Cellulitis | Not known |
Cephalea | Very Common |
Cerebral oedema (Brain oedema) | Not known |
Cerebrovascular disorders | Not known |
Chest pain | Very Common |
Cheyne-Stokes respiration | Not known |
Chills | Very Common |
Coma | Not known |
Congestive heart failure | Common |
Conjunctivitis | Very Common |
Constipation | Very Common |
Cough | Very Common |
Cystitis | Common |
Deafness | Not known |
Decreased appetite | Very Common |
Depression | Common |
Dermatitis | Not known |
Diarrhoea (Diarrhea) | Very Common |
Dry eye | Common |
Dry mouth (Xerostomia) | Common |
Dry skin | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Very Common |
Dyspnoea (dyspnea) | Very Common |
Dyspnoea exertional | Not known |
Dysuria (Micturition painful) | Not known |
Ejection fraction decreased | Common |
Epistaxis (Nasal bleeding) | Very Common |
Erysipelas | Not known |
Erythema | Very Common |
Face oedema | Very Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Gallop rhythm | Not known |
Gastritis | Not known |
Glomerulonephritis | Not known |
Glomerulonephritis membranous | Not known |
Haemorrhage subcutaneous | Common |
Haemorrhoids | Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Common |
Hepatocellular injury | Not known |
Herpes zoster | Common |
Hiccups | Not known |
Hot flush | Common |
Hyperhidrosis | Common |
Hyperkalaemia | Not known |
Hypersensitivity | Common |
Hypertension | Very rare |
Hypertonia | Common |
Hypoesthesia | Very Common |
Hypoprothrombinaemia | Not known |
Hypotension | Common |
Hypoxia | Not known |
Infection | Common |
Influenza | Very rare |
Influenza symptoms | Very Common |
Infusion related reaction | Very Common |
Insomnia | Very Common |
Interstitial pneumonitis | Not known |
Jaundice | Not known |
Lacrimation increased (Epiphora) | Very Common |
Laryngeal oedema | Not known |
Lethargy | Not known |
Leucopenia (Leukopenia) | Common |
Leukaemia | Not known |
Lip swelling | Very Common |
Liver tenderness | Common |
Lung disease | Not known |
Lung disorder | Common |
Lung infiltration (pulmonary infiltration) | Not known |
Lymphoedema | Very Common |
Maculopapular rash | Common |
Madarosis | Not known |
Malaise | Common |
Mastitis (breast inflammation) | Common |
Mastodynia | Common |
Meningitis | Not known |
Mucosal inflammation | Very Common |
Muscle cramps | Common |
Muscle tightness | Very Common |
Musculoskeletal pain | Common |
Myalgia | Very Common |
Nail disorders | Common |
Nail toxicity | Not known |
Nasopharyngitis | Very Common |
Nausea | Very Common |
Neck pain | Common |
Neuropathy peripheral | Common |
Neutropenia | Common |
Neutropenic sepsis | Not known |
Obnubilation | Very rare |
Oedema peripheral | Very Common |
Oligohydramnios | Not known |
Onychorrhexis | Not known |
Oropharyngeal pain | Very Common |
Orthopnoea | Not known |
Oxygen saturation decreased | Not known |
Pain | Very Common |
Pain in extremity (Pain in limb) | Very rare |
Palpitations | Common |
Pancreatitis | Common |
Papilloedema | Not known |
Paraesthesia (paresthesia) | Very Common |
Paraneoplastic cerebellar degeneration | Not known |
Pericardial effusion | Not known |
Pericarditis | Not known |
Pharyngitis | Common |
Pleural effusion | Common |
Pneumonia | Not known |
Progressive malignant neoplasia | Not known |
Progressive neoplasia | Not known |
Pruritus | Common |
Pulmonary fibrosis | Not known |
Pulmonary hypoplasia | Not known |
Pyrexia | Very Common |
Renal disorder | Common |
Renal hypoplasia | Not known |
Renal insufficiency | Not known |
Respiratory arrest | Not known |
Respiratory distress syndrome | Not known |
Respiratory failure | Not known |
Retinal haemorrhage | Not known |
Rhinitis | Common |
Rhinorrhoea | Very Common |
Septicemia | Not known |
Sinusitis | Common |
Skin Eruption | Very Common |
Skin infection | Common |
Somnolence | Common |
Stevens-Johnson syndrome | Not known |
Stomatitis | Very Common |
Supraventricular tachyarrhythmia | Common |
Tachycardia | Not known |
Thought disturbances | Very rare |
Thrombocytopenia (Thrombopenia) | Very Common |
Tremor | Very Common |
Upper respiratory tract infection | Common |
Urinary tract infection | Very rare |
Urticaria | Not known |
Vasodilation | Common |
Vertigo | Very Common |
Vomiting | Very Common |
Weight decreased (Weight loss) | Very Common |
Weight increased (weight gain) | Very Common |
Wheezing | Very Common |
Herzuma 440mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Herzuma 440mg MoH 10653 :
Form | Powder for concentrate for solution for infusion |
Packaging | Bottle |
Package Size | 1+1 |
Strength | 440mg |
Public Price | 1462608 L.L. |
Stratum | E2 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 177019/1 |
Submission date | 20/11/2019 |
Registration Year | 01/02/2022 |
Price Comparison
● Country: | The Netherlands | |
● Package Size: | 1 vial | |
● Public Price: | 1506.31 EUR | ( 145,925,287.56 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1506,31 EUR | ( 145,895,256.00 LBP ) |
● Pharmacy Price: | 1499.31 EUR | ( 145247155.56 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 24/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 1092 JOD | ( 136,741,332.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1092 JOD | ( 136,741,332.00 LBP ) |
● Pharmacy Price: | 1050 JOD | ( 131482050 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 1026.65 GBP | ( 116,677,745.85 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1026,65 GBP | ( 116,603,874.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 1 | |
● Public Price: | 1117.63 EUR | ( 108,271,523.88 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1117,63 EUR | ( 108,210,492.00 LBP ) |
● Exfactory Price: | 984.63 EUR | |
● Pharmacy Price: | 999.4 EUR | ( 96817874.4 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1 | |
● Public Price: | 967 EUR | ( 93,679,092.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 967 EUR | ( 93,679,092.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Powder for concentrate for solution for infusion | |
● Package Size: | 1+1 | |
● Public Price: | 1462608 LBP | ( 1,462,608.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1462608 LBP | ( 1,462,608.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Finland |
● Package Size: | 1 |
● Reference: | Kela |
● Pricing Date: | 22/04/2021 |
● Type: | Medicine Non Marketed |
● Country: | France |
● Package Size: | 1 |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
● Type: | Medicine Authorised |
● Country: | Spain |
● Package Size: | 1 vial |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios |
● Pricing Date: | 06/05/2021 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File